We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Dangers of Secondhand Smoke Confirmed

By HospiMedica staff writers
Posted on 20 Jul 2006
Nonsmokers exposed to secondhand smoke at home or work increase their risk of developing heart disease by 25-30% and lung cancer by 20-30%, according to a comprehensive report issued by the U.S. More...
Surgeon General.

The finding is of major public health concern due to the fact that nearly half of all nonsmoking Americans are still regularly exposed to secondhand smoke. Secondhand smoke, known as a human carcinogen, contains more than 50 cancer-causing chemicals. Nonsmokers who are exposed to secondhand smoke inhale many of the same toxins as smokers, and even brief exposure to secondhand smoke has immediate adverse effects on the cardiovascular system and increases the risk for heart disease and lung cancer.

In addition, the report noted that because the bodies of infants and children are still developing, they are especially vulnerable to the poisons in secondhand smoke, leading perhaps to problems such as sudden infant death syndrome (SIDS), respiratory problems, ear infections, and asthma attacks. The report said the only way to protect nonsmokers from the dangerous chemicals in secondhand smoke is to eliminate smoking indoors altogether, since even the most sophisticated ventilation systems cannot completely eliminate secondhand smoke exposure.

"The health effects of secondhand smoke exposure are more pervasive than we previously thought,” said U.S. Surgeon General Richard H. Carmona, vice admiral of the U.S. Public Health Service (Rockville, MD, USA). "The scientific evidence is now indisputable: secondhand smoke is not a mere annoyance. It is a serious health hazard that can lead to disease and premature death in children and nonsmoking adults.” Copies of the report are available on the Surgeon General's website.

The progress over the past 20 years in clearing the air of tobacco smoke is a major public health success story, said Surgeon General Carmona, who noted that levels of cotinine--a biologic marker for secondhand smoke exposure--measured in nonsmokers have fallen by 70% since the late 1980s, and the proportion of nonsmokers with detectable cotinine levels has been halved, from 88% in 1988-91 to 43% in 2001-02.



Related Links:
U.S. Surgeon General

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.